U.S., Aug. 27 -- An application to own the trademark for 'RINGTX' has been filed on Jan. 29, 2025.
Owner(s):
Ring Therapeutics, Inc.; 140 First Street, , MASSACHUSETTS
Goods and/or Services:
For: Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of human diseases and disorders; pharmaceutical preparations for use in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hem...